Weight Loss / Dual incretin
Tirzepatide
CompoundedTirzepatide is a prescription medicine that acts on GIP and GLP-1 receptors involved in appetite and food intake. A licensed clinician reviews your goals, medical history, medicines and individual risks, decides whether tirzepatide is appropriate and, if prescribing, selects the preparation and treatment plan. Ongoing use and changes require clinical direction.
Online enrollment opens soon.
- Adults 18 and older
- Eligibility depends on your location and health history
- Not available to patients covered by Medicare, Medicaid or TRICARE
- A completed review does not guarantee a prescription
Compounded medication
Compounded medicines are not FDA approved. FDA does not assess their safety, effectiveness or quality before marketing. They are not FDA-approved generics or interchangeable substitutes for approved medicines. A clinician must determine whether a compounded preparation is appropriate; the pharmacy is responsible for its preparation and labeling. Packaging shown is illustrative; the dispensed product may look different. This medicine is available only after an online evaluation and a prescription from a licensed clinician, if appropriate.
Important safety information
Tirzepatide can cause gastrointestinal effects, including nausea, vomiting, diarrhea and constipation, and has important warnings and contraindications. Tell the clinician about pregnancy or pregnancy plans, other medicines, and any personal or family history of medullary thyroid carcinoma or MEN 2. Read the full information for the medicine actually prescribed. Not for emergencies: call 911.
Billing, cancellation and refunds: Terms & Conditions · Returns, Refunds & Cancellation · Consent to Telehealth